Scott Walter, MD
Retina Specialist · Manchester, CTNPI 1205127818
Payments from drug & device makers
Across 380 payments — averaging $821.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$88K
- Regeneron Healthcare Solutions, Inc.$86K
- Apellis Pharmaceuticals, Inc.$64K
- Spark Therapeutics, Inc.$23K
- Bausch & Lomb Americas Inc.$15K
- Astellas Pharma US Inc$6K
- plus $31K from 19 others
Across 4 payments — averaging $704.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$3K
What the payments were for
- Consulting fees$74,76324%
- Speaking & faculty fees$198,20963%
- Travel & lodging$27,0139%
- Food & beverage$11,8684%
- Other$4680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 80 | $87,859 |
| Regeneron Healthcare Solutions, Inc. | 68 | $86,160 |
| Apellis Pharmaceuticals, Inc. | 54 | $64,409 |
| Spark Therapeutics, Inc. | 16 | $22,660 |
| Bausch & Lomb Americas Inc. | 40 | $14,790 |
| Astellas Pharma US Inc | 17 | $5,693 |
| AbbVie(2 entities) | 28 | $5,605 |
| Roche Products Limited | 1 | $4,920 |
| Novartis | 7 | $4,405 |
| Lupin Inc. | 2 | $3,735 |
| Regeneron | 4 | $3,533 |
| F. Hoffmann-la Roche AG | 2 | $2,326 |
| Genentech, Inc. | 3 | $2,260 |
| Eyepoint US, Inc. | 7 | $1,868 |
| Alcon | 7 | $765 |
| ANI Pharmaceuticals, Inc. | 22 | $335 |
| Alimera Sciences, Inc. | 9 | $302 |
| Immunocore Limited | 4 | $258 |
| Mallinckrodt Hospital Products Inc. | 2 | $142 |
| Dutch Ophthalmic, USA | 2 | $118 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Sandoz | 1 | $39 |
| Coherus Oncology, Inc. | 1 | $27 |
| Harrow Eye, LLC | 1 | $25 |
| Ocular Therapeutix, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few retina specialist providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 47 | $18,558 |
| Prednisolone Acetate | 272 | $14,749 |
| Bromfenac Sodium | 71 | $11,216 |
| Loteprednol Etabonate | 24 | $4,722 |
| Atropine Sulfate | 110 | $4,141 |
| Latanoprost | 149 | $1,574 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 163 | $1,482 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 26 | $1,298 |
| Ketorolac Tromethamine | 42 | $1,078 |
| Brimonidine Tartrate | 39 | $899 |
| Dorzolamide Hcl | 46 | $720 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 104 | $694 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 25 | $365 |
| Timolol Maleate | 39 | $340 |
| Cyclopentolate Hcl | 22 | $223 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Manchester
- Greg BudoffManchester$5K
- Nauman ChaudhryWaterford$7.3M
- Richard ScartozziDanbury$694K
- Juner Colina BiscottoWaterford$686K
- Armand DaccacheDanbury$3K
- Stephanie SuginWaterbury$2K
- Craig SklarWaterbury$2K
- Tomasz WiraszkaWaterbury$2K
- Vincent ReppucciDanbury$1K
- Jennifer NadelmannNew Haven$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.